© 1999 European Society of Cardiology
Perindopril for elderly people with chronic heart failure: the PEP-CHF study
University of Hull, Castle Hill Hospital Kingston-upon-Hull HU16 5JQ, UK
* Corresponding author. Tel.: +44-1482-624084; fax: +44-1482-624085.
 |
Abstract |
|---|
Background: The prevalence of chronic heart failure (CHF) rises with increasing age, from <1% in those below 65 years of age to > 5% in those over 65 years of age and is a major cause of morbidity and mortality in older people. Recent European guidelines point to a major deficiency in our knowledge of how to treat diastolic chronic heart failure, and a lack of information on treatment for heart failure in the elderly in general.
Aims: The aims of this trial are to assess the potential benefits of the ACE inhibitor perindopril to treat chronic heart failure in elderly people, in the absence of any major left ventricular systolic dysfunction.
Subjects: One thousand people over the age of 70 years will be recruited into this study. Evidence of chronic heart failure will be confirmed by clinical criteria and echocardiography.
Methods: Once a diagnosis of chronic heart failure has been confirmed, the patient will receive either perindopril or placebo in addition to their usual treatment. Death, and unplanned heart failure related hospitalisations, are the primary outcomes. Quality of life, as measured by the Guyatt questionnaire will be assessed at the beginning of the study and at 1 year. Sub-studies of this trial include a 6-min walking test and more detailed evaluation of ventricular function (as assessed by echocardiography). Both parameters will be measured at 8 weeks and 1 year, and analysed against baseline data. Cognitive function in this group of patients will also be evaluated at baseline and 1 year. This trial is due to report in the year 2001.
Key Words: ACE inhibitors • Perindopril • Chronic heart failure • Elderly • Quality of life
Received June 28, 1999; Revised July 1, 1999; Accepted July 1, 1999
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Zannad, N. Agrinier, and F. Alla Heart failure burden and therapy Europace, November 1, 2009; 11(suppl_5): v1 - v9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Rosolova, J. Cech, J. Simon, J. Spinar, R. Jandova, J. Widimsky sen, L. Holubec, and O. Topolcan Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey Eur J Heart Fail, August 1, 2005; 7(5): 780 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, and A. G. Oliveira Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy Eur J Heart Fail, October 1, 2004; 6(6): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Thomas, K. F. Fox, A. J.S. Coats, and G. C. Sutton The epidemiological enigma of heart failure with preserved systolic function Eur J Heart Fail, March 1, 2004; 6(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Coletta, J. G.F. Cleland, N. Freemantle, H. Loh, A. Memon, and A. L. Clark Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM Eur J Heart Fail, October 1, 2003; 5(5): 697 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J.W. van Kraaij, P.E.J. van Pol, A.W. Ruiters, J.B.R.M. de Swart, D.J. Lips, N. Lencer, and P.A.F.M. Doevendans Diagnosing diastolic heart failure Eur J Heart Fail, August 1, 2002; 4(4): 419 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Taylor and D. J. Stott Chronic heart failure and cognitive impairment: co-existence of conditions or true association? Eur J Heart Fail, January 1, 2002; 4(1): 7 - 9. [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland ACE Inhibitors for 'Diastolic' Heart Failure? Reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure Eur J Heart Fail, December 1, 2001; 3(6): 637 - 639. [Full Text] [PDF]
|
|
|
|
|
|
K. McDonald, M. Ledwidge, J. Cahill, J. Kelly, P. Quigley, B. Maurer, F. Begley, M. Ryder, B. Travers, L. Timmons, et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge Eur J Heart Fail, March 1, 2001; 3(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sanderson Letter to the editor Eur J Heart Fail, March 1, 2000; 2(1): 115 - 115. [Full Text] [PDF]
|
|
|
|
|
|
C. G. Jones and J. G.F. Cleland The LIDO, HOPE, MOXCON and WASH studies Eur J Heart Fail, December 17, 1999; 1(4): 425 - 431. [Abstract] [Full Text] [PDF]
|
|